GaryLBryantMD

Rheumatology • Minneapolis, MN

Lupus & Related, Rheumatoid Arthritis & Related

Professor Rheumatic and Autoimmune Diseases University of Minnesota Medical School

Join to view full profile

Dr. Bryant is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bryant's full profile

Already have an account?

Office
Variety Club Research Center STE. 131, MMC 108
401 East River Parkway
Minneapolis, MN 55455
Phone+1 612-626-9694
Is this information wrong?

Education & Training

Brigham & Women's Hosp1981 - 1983
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1977 - 1980
University of Nebraska College of MedicineClass of 1977

Certifications & Licensure

WI State Medical License 1983 - 2025
MN State Medical License 2007 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Master of the American College of Rheumatology American College of Rheumatology, 2018
Paulding Phelps Award American College of Rheumatology, 2011
Distinguished Service Award Wisconsin Medical Society, 2007
Alpha Omega Alpha University of Nebraska College of Medicine, 1977
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Join now to see all

Publications & Presentations

PubMed

63 citations
A comparison of two treatment regimens of ceftriaxone in late Lyme disease.
Raymond J. Dattwyler, Gary P. Wormser, Thomas J. Rush, Michael F. Finkel, Robert T. Schoen, Edgar Grunwaldt, Michael Franklin, Eileen Hilton, Gary L. Bryant, William A...> ;Wiener Klinische Wochenschrift. 2005 Jun 1
264 citations
A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent lyme disease
Leonard H. Sigal, J M Zahradnik, P Lavin, S J Patella, Gary L. Bryant, R. Haselby, E Hilton, M. Kunkel, D. Adler-Klein, T. Doherty, J. Evans, Philip J. Molloy, A L Sei...> ;The New England Journal of Medicine. 1998 Jul 23
39 citations
Characterization of the Protective Borreliacidal Antibody Response in Humans and Hamsters after Vaccination with a Borrelia burgdorferi Outer Surface Protein A Vaccine
Marcia L. Padilla, Steven M. Callister, Ronald F. Schell, Gary L. Bryant, Dean A. Jobe, Steven D. Lovrich, B. K. Duchateau, Jani R. Jensen> ;The Journal of Infectious Diseases. 1996 Oct 1
24 citations
Detection of borreliacidal antibodies by flow cytometry. An accurate, highly specific serodiagnostic test for Lyme disease
Steven M. Callister, Ronald F. Schell, L. C. L. Lim, Dean A. Jobe, Kay L. Case, Gary L. Bryant, Paul E. Molling> ;Archives of Internal Medicine. 1994 Jul 25
15 citations
Lyme disease: clinical features, classification, and epidemiology in the upper midwest.
William A. Agger, Kay L. Case, Gary L. Bryant, Steven M. Callister> ;Medicine. 1991 Mar 1
28 citations
Diagnostic value of the history and examination in giant cell arteritis: a clinical pathological study of 81 temporal artery biopsies
Celeste Robb-Nicholson, R W Chang, S Anderson, W N Roberts, J Longtine, Joseph M. Corson, Martin G. Larson, David L. George, J Green, Gary L. Bryant> ;The Journal of Rheumatology. 1988 Dec 1
10 citations
Cerebral vasculopathy: An analysis of sixteen cases
Gary L. Bryant, Michael E. Weinblatt, Calvin L. Rumbaugh, Jonathan S. Coblyn> ;Seminars in Arthritis and Rheumatism. 1986 May 1
Join now to see all

Press Mentions

ACR Leads AMA Resolution on Payer Financial Incentives to Patients to Switch TreatmentMay 22nd, 2021
Successful Resolutions, Policy Updates at AMA House of Delegates 2020 Interim MeetingJanuary 24th, 2021
ACR/ARHP Members Call on Congress to Restore Patients’ VoicesMay 21st, 2018